14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 3rd May 2024 BMRN stock ended at $82.44. This is 1.62% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.01% from a day low at $82.32 to a day high of $84.80.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Dec 13, 2021 $84.60 $85.33 $83.34 $83.79 1 363 728
Dec 10, 2021 $85.46 $85.88 $84.04 $84.89 1 111 266
Dec 09, 2021 $88.07 $88.91 $85.49 $85.62 1 352 125
Dec 08, 2021 $86.79 $89.05 $85.85 $88.38 1 030 681
Dec 07, 2021 $85.31 $86.62 $84.71 $86.12 1 227 083
Dec 06, 2021 $81.90 $84.97 $81.16 $84.24 989 094
Dec 03, 2021 $84.24 $84.97 $82.35 $82.95 1 300 152
Dec 02, 2021 $84.93 $85.89 $84.15 $84.68 990 143
Dec 01, 2021 $86.27 $88.31 $84.01 $84.50 1 210 646
Nov 30, 2021 $85.88 $88.17 $85.50 $86.29 3 433 161
Nov 29, 2021 $88.16 $89.02 $87.19 $87.40 1 146 770
Nov 26, 2021 $89.55 $89.74 $86.26 $87.58 920 985
Nov 24, 2021 $89.47 $90.12 $88.80 $89.57 930 107
Nov 23, 2021 $89.44 $90.70 $88.11 $89.79 1 859 409
Nov 22, 2021 $91.80 $92.17 $90.12 $90.30 1 857 413
Nov 19, 2021 $83.54 $91.72 $82.24 $91.47 6 175 138
Nov 18, 2021 $81.07 $83.13 $80.55 $82.92 1 836 777
Nov 17, 2021 $80.87 $82.09 $80.39 $80.74 1 211 963
Nov 16, 2021 $82.55 $83.14 $81.17 $81.30 1 054 859
Nov 15, 2021 $82.46 $82.98 $81.90 $82.07 1 117 463
Nov 12, 2021 $81.60 $81.97 $81.30 $81.73 863 779
Nov 11, 2021 $81.51 $82.16 $81.01 $81.44 1 409 656
Nov 10, 2021 $82.09 $83.80 $81.19 $81.54 1 072 025
Nov 09, 2021 $83.11 $83.57 $81.95 $82.76 1 320 813
Nov 08, 2021 $83.92 $84.67 $83.26 $83.43 1 430 875
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT